Preview Mode Links will not work in preview mode

WorkParty


Dec 23, 2020

This episode is brought to you by Phexxi® (lactic acid, citric acid, and potassium bitartrate) Vaginal Gel 1.8%, 1%, 0.4%, which is an FDA-approved, hormone-free,  prescription birth control used only before sex. Phexxi works to maintain the  vaginal pH level to prevent pregnancy and you only use it when you need it! Be  sure to tell your healthcare provider if you have a recent history of 3 or more UTIs  per year. Learn more, including all risks at Phexxi.com.

Disrupting an industry is no easy task. Just ask Saundra Pelletier. As the CEO of the  biopharmaceutical company Evofem, she’s making major moves in a multi-billion dollar market that hasn’t been disrupted in nearly 30 years: the contraceptive  industry. Despite the fact that the global contraceptive market size was valued at  $22 billion in 2019 and is projected to reach over $30 billion by 2027, there has  been little innovation in the space since the 90s. But Saundra is working to change  that at Evofem. The company’s latest product Phexxi, a prescription contraceptive  gel, is a hormone-free option that allows women to be in control of their sexual  and reproductive health. But Saundra’s not just at the forefront of disrupting the  contraceptive industry on the pharmaceutical side. She’s also advocating for  change in the space via the nonprofit sector as the co-founder of WomanCare Global, a nonprofit provider of health care products to women around the world.  In this episode of WorkParty, we sit down with Saundra to talk about her  impressive career, her commitment to giving women access to more choices, and  her role as a mentor for a new generation of women coming up behind her.  

Visit PHEXXI.com for full information on use and risks  

Join the party on social @workparty and stay in-the-know at workparty.com

Guest 

Saundra Pelletier @saundrapelletierofficial @evofembiosciences @phexxi

Produced by Dear Media